Liabilities / Assets
58th percentile
Higher debt load relative to assets than 58% of similar nonprofits.
990EZ • Fiscal year 2016 • EIN 45-0494175
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
58th percentile
Higher debt load relative to assets than 58% of similar nonprofits.
Liabilities / Revenue
65th percentile
Higher debt load relative to revenue than 65% of similar nonprofits.
Net Margin
78th percentile
Higher net margin than 78% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
55th percentile
Faster asset growth than 55% of similar nonprofits.
Revenue Growth
12th percentile
Faster revenue growth than 12% of similar nonprofits.
Assets
Up$239,807
Up $10,334 (+4.5%) from 2015
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Down$612
Down $42 (-6.4%) from 2015
Revenue
Down$48,557
Down $35,136 (-42%) from 2015
Expenses
Up$38,262
Up $3,714 (+11%) from 2015
Net Income
Down$10,295
Down $38,850 (-79%) from 2015
This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To provide cancer patients in need with medications and medical expenses associated with their treatment and not otherwise covered by insurance or other agencies. Each patient is eligible to be reimbursed $2.000 per year for medications, protheses, medical supplies and medical expenses. A new patient is eligible for a one-time initial grant of $500 to be used as desired after being diagnosed with cancer or blood disease.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2016 • Form 990EZSummary only. Only limited summary data is available for this year.